SUCAMPO PHARMA LLC FDA Approval NDA 021214

NDA 021214

SUCAMPO PHARMA LLC

FDA Drug Application

Application #021214

Documents

Label2012-12-10
Review2004-06-16
Review2015-11-18
Review2015-11-17
Letter2000-08-03
Label2000-08-03
Label2012-12-10

Application Sponsors

NDA 021214SUCAMPO PHARMA LLC

Marketing Status

Discontinued001

Application Products

001SOLUTION/DROPS;OPHTHALMIC0.15% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1RESCULAUNOPROSTONE ISOPROPYL

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2000-08-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2012-12-07PRIORITY
LABELING; LabelingSUPPL7AP2012-12-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2014-07-10PRIORITY

Submissions Property Types

SUPPL1Null0
SUPPL6Null0
SUPPL7Null15
SUPPL8Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21214
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.